01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
On June 19th, the New York State Senate and Assembly voted to pass omnibus legislation greatly stren...
Read More >
A California federal court decertified a class of millions of Walmart employees after concluding tha...
Read More >
On June 26, 2019, Governor Ned Lamont signed a $43.4 billion budget for the 2020 and 2021 fiscal yea...
Read More >
New Jersey has amended its Wage Payment Law (WPL) to require employers with at least 10 employees to...
Read More >
I read a very interesting article in the Epstein Becker Wage & Hour Defense Blog, whose sentiments I...
Read More >
Unpaid interns are not “employees” as defined by the National Labor Relations Act (NLRA), and empl...
Read More >